Multi-component pharmacokinetic study of prunus mume fructus extract after oral administration in rats using UPLC-MS/MS

Multi-component pharmacokinetic study of prunus mume fructus extract after oral administration in rats using UPLC-MS/MS

Prunus mume fructus (MF) is used in traditional Chinese medicine and food, as it exerts pharmacological effects, such as antibacterial, antioxidant, antitumour, thirst-relieving, and antidiarrheal effects. In the present study, a reliable and sensitive ultra-high performance liquid chromatography/ta...

Full description

Bibliographic Details
Main Authors:	Yameng Zhu, Shujie Wei, Xiunan Cao, Songrui Wang, Yanxu Chang, Huizi Ouyang, Jun He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-09-01
Series:	Frontiers in Pharmacology
Subjects:	Prunus mume fructus extract prototype components pharmacokinetic rat plasma UPLC-MS/MS
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.954692/full

Similar Items

Comparative Investigation of the Differences in Chemical Compounds between Raw and Processed <i>Mume Fructus</i> Using Plant Metabolomics Combined with Chemometrics Methods
by: Songrui Wang, et al.
Published: (2022-09-01)

Structural Characterization of Chemical Compounds Based on Their Fragmentation Rules in Sophorae Fructus by UPLC-QTOF-MS/MS
by: Zi-Hui He, et al.
Published: (2022-09-01)

Integrated UPLC/Q-TOF-MS/MS Analysis and Network Pharmacology to Reveal the Neuroprotective Mechanisms and Potential Pharmacological Ingredients of Aurantii Fructus Immaturus and Aurantii Fructus
by: Mingyang Qiu, et al.
Published: (2024-02-01)

Identification and Comparison of Constituents of Aurantii Fructus and Aurantii Fructus Immaturus by UFLC-DAD-Triple TOF-MS/MS
by: Yang Bai, et al.
Published: (2018-03-01)

Fructus mume Extracts Alleviate Diarrhea in Breast Cancer Patients Receiving the Combination Therapy of Lapatinib and Capecitabine
by: Hua Xing, et al.
Published: (2018-05-01)

Determination of oleandrin and adynerin in rat plasma by UPLC–MS/MS and their pharmacokinetic study
by: Meiling Zhang, et al.
Published: (2022-12-01)

Antiplatelet and antithrombotic effect of Phyllostachys pubescens leaves and Mume Fructus combination
by: Wen Yi Jin, et al.
Published: (2013-06-01)

Development of an UPLC-MS/MS method for quantitative analysis of abexinostat levels in rat plasma and application of pharmacokinetics
by: Yige Yu, et al.
Published: (2024-02-01)

UPLC–MS/MS for the determination of azilsartan in beagle dog plasma and its application in a pharmacokinetics study
by: Cheng Gong, et al.
Published: (2015-06-01)

Pharmacokinetics of active compounds of a Terminalia chebula Retz. Ethanolic extract after oral administration rats using UPLC-MS/MS
by: Guangzhe Yao, et al.
Published: (2023-01-01)

Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
by: Ming Li, et al.
Published: (2022-07-01)

Development of UPLC-MS/MS Method for Studying the Pharmacokinetic Interaction Between Dasatinib and Posaconazole in Rats
by: Yang S, et al.
Published: (2021-05-01)

De novo transcriptome assembly of two different Prunus mume cultivars
by: Yeonhwa Jo, et al.
Published: (2015-12-01)

Simultaneous Determination of Parecoxib and Its Metabolite Valdecoxib Concentrations in Beagle Plasma by UPLC-MS/MS and Application for Pharmacokinetics Study
by: Li S, et al.
Published: (2020-03-01)

Pharmacokinetics of Herb-Drug Interactions of Plumbagin and Tazemetostat in Rats by UPLC-MS/MS
by: Li H, et al.
Published: (2022-09-01)

An Ultra-Performance Liquid Chromatography–Tandem Mass Spectrometry (UPLC–MS/MS) Method for Qualifying DAPB in Rat Plasma and Application to Pharmacokinetic Studies
by: Bei Qin, et al.
Published: (2024-01-01)

Headspace Volatiles and Endogenous Extracts of <i>Prunus mume</i> Cultivars with Different Aroma Types
by: Xueqin Wang, et al.
Published: (2021-11-01)

Determination of parecoxib and valdecoxib in rat plasma by UPLC-MS/MS and its application to pharmacokinetics studies
by: Mengchun Chen, et al.
Published: (2020-04-01)

Pharmacokinetics, Bioavailability, and Tissue Distribution of the Kirsten Rat Sarcoma Inhibitor Adagrasib in Rats Using UPLC-MS/MS
by: Lei P, et al.
Published: (2024-01-01)

Pharmacokinetics of niazirin from Moringa oleifera Lam in rats by UPLC‐MS/MS: Absolute bioavailability and dose proportionality
by: Fang Wang, et al.
Published: (2022-12-01)

Development of an UPLC-MS/MS Method for the Quantitative Analysis of Upadacitinib in Beagle Dog Plasma and Pharmacokinetics Study
by: Wang MJ, et al.
Published: (2021-10-01)

A pharmacokinetic study on twenty-one compounds in rat plasma by integrating UPLC-QQQ-MS/MS with GC-MS after oral administration of Suxiao Jiuxin pill
by: Ye Shang, et al.
Published: (2024-01-01)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique
by: Wang H, et al.
Published: (2021-11-01)

Determination of Aflatoxins in Grains by QuEChERS-UPLC-MS/MS
by: WU Qin-yan, et al.
Published: (2024-03-01)

Volatile Metabolome and Aroma Differences of Six Cultivars of <i>Prunus mume</i> Blossoms
by: Ting Li, et al.
Published: (2023-01-01)

Eco-Friendly UPLC–MS/MS Method for Determination of a Fostamatinib Metabolite, Tamatinib, in Plasma: Pharmacokinetic Application in Rats
by: Essam Ezzeldin, et al.
Published: (2021-07-01)

Analytical methodology and pharmacokinetic study of elagolix in plasma of rats using a newly developed UPLC-MS/MS assay
by: Qiong Wang, et al.
Published: (2021-07-01)

Herb-drug interactions of silybinin and cilofexor in beagle dogs based on pharmacokinetics by UPLC-MS/MS
by: Xinyi Wei, et al.
Published: (2024-02-01)

The Pharmacokinetic Effect of Itraconazole and Voriconazole on Ripretinib in Beagle Dogs by UPLC-MS/MS Technique [Corrigendum]
by: Wang H, et al.
Published: (2023-11-01)

Development of UPLC-MS/MS Method to Study the Pharmacokinetic Interaction between Sorafenib and Dapagliflozin in Rats
by: Xueru He, et al.
Published: (2022-09-01)

Establishment and Verification of UPLC-MS/MS Technique for Pharmacokinetic Drug–Drug Interactions of Selinexor with Posaconazole in Rats
by: Zhou C, et al.
Published: (2021-04-01)

Análise de fármacos em águas por SPE-UPLC-ESI-MS/MS
by: Vanessa de Jesus Gaffney, et al.
Published: (2014-01-01)

Validation of UPLC-MS/MS Method for Determination of Urinary Lactulose/Mannitol
by: Jacopo Gervasoni, et al.
Published: (2018-10-01)

Simultaneous determination of amiodarone, dronedarone, and their principal metabolites in SD rat plasma by UPLC-MS/MS and its application in pharmacokinetics
by: Ying Zhang, et al.
Published: (2021-08-01)

Simultaneous determination of tofacitinib and its principal metabolite in beagle dog plasma by UPLC-MS/MS and its application in pharmacokinetics
by: Qiong Wang, et al.
Published: (2022-01-01)

An UPLC-MS/MS method to monitor Estriol injection and comparison of pharmacokinetic characteristics after irradiation
by: Hanming Zhang, et al.
Published: (2021-06-01)

Quantitative Analysis of Eight Compounds in Traditional Korean Medicine, Gongjindan Using HPLC, UPLC–MS/MS, and GC–MS/MS Systems
by: Chang-Seob Seo, et al.
Published: (2023-03-01)

UPLC-MS/MS Measurement of the Effect of Isavuconazole, Itraconazole and Fluconazole on the Pharmacokinetics of Selinexor in Rats
by: Li S, et al.
Published: (2020-09-01)

UPLC-MS/MS Technology for the Quantitative Methodology and Pharmacokinetic Analysis of Voxtalisib in Rat Plasma
by: Qingqing Li, et al.
Published: (2022-06-01)

Pharmacokinetic and Metabolism Studies of 12-Riboside-Pseudoginsengenin DQ by UPLC-MS/MS and UPLC-QTOF-MSE
by: Zhenzhou Wang, et al.
Published: (2018-09-01)